Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Shah BD"'
Publikováno v:
In Value in Health January 2022 25(1) Supplement:S238-S238
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Roloff GW; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL., Aldoss I; Division of Leukemia, Department of Hematology and Hematopoitic Cell Transplantation, City of Hope National Medical Center, Duarte, CA., Kopmar NE; Division of Hematology and Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA., Lin C; Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC., Dekker SE; Division of Hematology-Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR., Gupta VK; Division of Hematology & Oncology, University of California Los Angeles, Los Angeles, CA., O'Connor TE; Division of Hematology/Oncology, Cardinal Bernardin Cancer Center, Loyola University Medical Center, Maywood, IL., Jeyakumar N; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA., Muhsen IN; Section of Hematology and Oncology, Department of Medicine, Baylor College of Medicine, Houston, TX., Valtis Y; Memorial Sloan Kettering Cancer Center, New York, NY., Ahmed N; Memorial Sloan Kettering Cancer Center, New York, NY., Zhang A; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA., Miller K; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA., Dykes KC; Department of Medicine, Division of Hematology and Oncology, University of California San Diego Moores Cancer Center, San Diego, CA., Ahmed M; Cedars-Sinai Medical Center, Los Angeles, CA., Chen EC; Adult Leukemia Program, Dana-Farber Cancer Institute, Boston, MA., Mercadal S; Transplant and Cellular Therapy Program, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT., Schwartz M; University of Colorado Anschutz School of Medicine, Aurora, CO., Tracy SI; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN., Dholaria B; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN., Mukherjee A; University of Arkansas Medical Center, Little Rock, AK., Battiwalla M; Sarah Cannon Transplant and Cell Therapy Network, Nashville, TN., Logan AC; Department of Medicine, Division of Hematology and Blood and Marrow Transplantation, University of California, San Francisco, CA., Ladha A; Department of Hematology, Norris Cancer Center, University of Southern California, Los Angeles, CA., Guzowski C; Blood and Marrow Transplant Program, Northside Hospital, Atlanta, GA., Hoeg RT; Department of Internal Medicine, Division of Hematology and Oncology, University of California Davis School of Medicine, Sacramento, CA., Hilal T; Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ., Moore J; Division of Hematology/Oncology, Department of Medicine, James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY., Connor MP; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA., Hill LC; Center for Cell and Gene Therapy, Baylor College of Medicine and Houston Methodist Hospital, Houston, TX., Tsai SB; Division of Hematology/Oncology, Cardinal Bernardin Cancer Center, Loyola University Medical Center, Maywood, IL., Sasine JP; Cedars-Sinai Medical Center, Los Angeles, CA., Solh MM; Blood and Marrow Transplant Program, Northside Hospital, Atlanta, GA., Kota VK; Georgia Cancer Center, Augusta University, Augusta, GA., Koura D; Department of Medicine, Division of Hematology and Oncology, University of California San Diego Moores Cancer Center, San Diego, CA., Veeraputhiran M; University of Arkansas Medical Center, Little Rock, AK., Leonard JT; Division of Hematology-Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR., Frey NV; Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA., Park JH; Memorial Sloan Kettering Cancer Center, New York, NY., Luskin MR; Adult Leukemia Program, Dana-Farber Cancer Institute, Boston, MA., Bachanova V; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN., Galal A; Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC., Pullarkat V; Division of Leukemia, Department of Hematology and Hematopoitic Cell Transplantation, City of Hope National Medical Center, Duarte, CA., Stock W; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL., Cassaday RD; Division of Hematology and Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA., Shah BD; Moffitt Cancer Center, Tampa, FL., Faramand R; Moffitt Cancer Center, Tampa, FL., Muffly L; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Oct 17, pp. JCO2400321. Date of Electronic Publication: 2024 Oct 17.
Autor:
Minnema MC; University Medical Center Utrecht, Utrecht, Netherlands., Yin X; Medidata Solutions, New York, NY, USA., Davi R; Medidata Solutions, New York, NY, USA., Keeping S; PRECISIONheor, Vancouver, Canada., Park JE; PRECISIONheor, Vancouver, Canada., Itani T; Kite, a Gilead Company, Santa Monica, CA, USA., Hadjivassileva T; Kite, a Gilead Company, Santa Monica, CA, USA., Castaigne JG; Kite, a Gilead Company, Santa Monica, CA, USA., Damico Khalid R; Kite, a Gilead Company, Santa Monica, CA, USA., Zhou L; Kite, a Gilead Company, Santa Monica, CA, USA., Wu JJ; Kite, a Gilead Company, Santa Monica, CA, USA., Shah BD; Moffitt Cancer Center, Tampa, FL, USA.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2024 Oct; Vol. 65 (10), pp. 1438-1447. Date of Electronic Publication: 2024 May 24.
Autor:
Hoogland AI; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida. Electronic address: aasha.hoogland@moffitt.org., Barata A; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts., Li X; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida., Irizarry-Arroyo N; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida., Jain MD; Department of Blood and Marrow Transplantation and Cellular Therapy, Moffitt Cancer Center, Tampa, Florida., Welniak T; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida., Rodriguez Y; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida., Oswald LB; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida., Gudenkauf LM; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida., Chavez JC; Department of Blood and Marrow Transplantation and Cellular Therapy, Moffitt Cancer Center, Tampa, Florida., Khimani F; Department of Blood and Marrow Transplantation and Cellular Therapy, Moffitt Cancer Center, Tampa, Florida., Lazaryan A; Department of Blood and Marrow Transplantation and Cellular Therapy, Moffitt Cancer Center, Tampa, Florida., Liu HD; Department of Blood and Marrow Transplantation and Cellular Therapy, Moffitt Cancer Center, Tampa, Florida., Nishihori T; Department of Blood and Marrow Transplantation and Cellular Therapy, Moffitt Cancer Center, Tampa, Florida., Pinilla-Ibarz J; Department of Blood and Marrow Transplantation and Cellular Therapy, Moffitt Cancer Center, Tampa, Florida., Shah BD; Department of Blood and Marrow Transplantation and Cellular Therapy, Moffitt Cancer Center, Tampa, Florida., Crowder SL; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida., Parker NH; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida., Carson TL; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida., Vinci CE; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida., Pidala JA; Department of Blood and Marrow Transplantation and Cellular Therapy, Moffitt Cancer Center, Tampa, Florida., Logue J; Moffitt Malignant Hematology & Cellular Therapy, Memorial Healthcare System, Pembroke Pines, Florida., Locke FL; Department of Blood and Marrow Transplantation and Cellular Therapy, Moffitt Cancer Center, Tampa, Florida., Jim HSL; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida.
Publikováno v:
Transplantation and cellular therapy [Transplant Cell Ther] 2024 Sep 19. Date of Electronic Publication: 2024 Sep 19.
Autor:
Zhang Y; Department of Malignant Hematology, Tampa, Florida., Rose A; Department of Malignant Hematology, University of Miami Health System, Miami, Florida., Khadka S; Department of Malignant Hematology, Tampa, Florida; Department of Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida., Cao B; Department of Biostatistics and Bioinformatics, Tampa, Florida., Eatrides J; Department of Malignant Hematology, Tampa, Florida., Saeed H; Department of Malignant Hematology, Tampa, Florida., Shah BD; Department of Malignant Hematology, Tampa, Florida., Chavez J; Department of Malignant Hematology, Tampa, Florida., Bello C; Department of Malignant Hematology, Tampa, Florida., Lazaryan A; Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Tampa, Florida., Khimani F; Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Tampa, Florida., Ibarz JP; Department of Malignant Hematology, Tampa, Florida., Liu HD; Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Tampa, Florida., Locke FL; Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Tampa, Florida., Jain MD; Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Tampa, Florida., Zhang L; Department of Hematopathology, Moffitt Cancer Center & Research Institute, Tampa, Florida., Kharfan-Dabaja MA; Division of Hematology/Oncology and Blood and Marrow Transplantation and Cellular Therapy, Mayo Clinic, Jacksonville, Florida., Kim J; Department of Biostatistics and Bioinformatics, Tampa, Florida., Ayala E; Division of Hematology/Oncology and Blood and Marrow Transplantation and Cellular Therapy, Mayo Clinic, Jacksonville, Florida., Nishihori T; Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Tampa, Florida. Electronic address: taiga.nishihori@moffitt.org., Sokol L; Department of Malignant Hematology, Tampa, Florida.
Publikováno v:
Transplantation and cellular therapy [Transplant Cell Ther] 2024 Sep; Vol. 30 (9), pp. 887.e1-887.e9. Date of Electronic Publication: 2024 May 11.